Japanese | English |
Œ¤‹†ŽÒƒf[ƒ^ƒx[ƒX | |
–¼‘OF | ‘º“c ‹M”V(Takayuki Murata) |
Œ¤‹†•ª–ì‚ÌKeywordF | EBƒEƒCƒ‹ƒX
ŠÌ‰ŠƒEƒCƒ‹ƒX ƒEƒCƒ‹ƒX”‚ª‚ñ RƒEƒCƒ‹ƒX–ò ƒ^ƒ“ƒpƒNŽ¿‚Ì–|–óŒãCü ƒVƒOƒiƒ‹“`’B ƒGƒsƒWƒFƒlƒeƒBƒbƒNƒX‚Æ“]ŽÊ |
Š‘®‹@ŠÖ/‘gD (#1) | |
Š‘®‹@ŠÖ–¼-1F | “¡“c•ÛŒ’‰q¶‘åŠw |
Š‘®•”–¼(1) 1F | ˆãŠw•”@ˆãŠw‰È |
–ðEEE–¼-1F | ‹³Žö |
—X•Ö”Ô†-1F | 470-1192 |
ZŠ-1F | ˆ¤’mŒ§–L–¾ŽsŒBŠ|’¬“cŠyƒ–ŒE1-98 |
“d˜b”Ô†-1F | 0562-93-2634 |
FAX”Ô†-1F | 0562-93-4593 |
‹³ˆçî•ñ (#1) | |
‰È–Ú–¼-1F | ƒEƒCƒ‹ƒXEŠñ¶’ŽŠw |
Š‘®Šw‰ï^Œ¤‹†‰ï (#1) | |
Š‘®Šw‰ï–¼-1F | “ú–{ƒEƒCƒ‹ƒXŠw‰ï |
Š‘®Šw‰ï–ðˆõEˆÏˆõ‰ï“™-1F | •]‹cˆõ |
Š‘®Šw‰ï^Œ¤‹†‰ï (#2) | |
Š‘®Šw‰ï–¼-2F | “ú–{ŠàŠw‰ï |
Š‘®Šw‰ï–ðˆõEˆÏˆõ‰ï“™-2F | ‰ïˆõ |
Œ¤‹†—ð^ŽÀÑ [2017”N] (#24) | |
˜_•¶-24F | Yoshida M, Murata T*, Ashio K, Narita Y, Watanabe T, Masud HMAA, Sato Y, Goshima F, Kimura H. Characterization of a Suppressive Cis-acting Element in the Epstein-Barr Virus LMP1 Promoter. Front Microbiol. 2017 Nov 22;8:2302.
Masud HMAA, Watanabe T, Yoshida M, Sato Y, Goshima F, Kimura H, Murata T*. Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production. J Virol. 2017 Nov 14;91(23). pii: e00975-17. Yoshida M, Watanabe T, Narita Y, Sato Y, Goshima F, Kimura H, Murata T*. The Epstein-Barr Virus BRRF1 Gene Is Dispensable for Viral Replication in HEK293 cells and Transformation. Sci Rep. 2017 Jul 20;7(1):6044. Watanabe T, Sakaida K, Yoshida M, Masud HMAA, Sato Y, Goshima F, Kimura H, Murata T*. The C-Terminus of Epstein-Barr Virus BRRF2 Is Required for its Proper Localization and Efficient Virus Production. Front Microbiol. 2017 Jan 31;8:125. |
Œ¤‹†—ð^ŽÀÑ [2018”N] (#25) | |
˜_•¶-25F | Konishi N, Narita Y, Hijioka F, Masud HMAA, Sato Y, Kimura H, Murata T*. BGLF2 Increases Infectivity of Epstein-Barr Virus by Activating AP-1 upon De Novo Infection. mSphere. 2018 Apr 25;3(2). pii: e00138-18. |
Fri Jun 1 13:37:07 JST 2018